Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL.

Leukemia·2017
Same author

The pre-rRNA processing factor DEF is rate limiting for the pathogenesis of MYCN-driven neuroblastoma.

Oncogene·2017
Same author

Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia.

Leukemia·2016
Same author

Overexpression of PDGFRA cooperates with loss of NF1 and p53 to accelerate the molecular pathogenesis of malignant peripheral nerve sheath tumors.

Oncogene·2016
Same author

Studying the peripheral sympathetic nervous system and neuroblastoma in zebrafish.

Methods in cell biology·2016
Same author

KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells.

Leukemia·2016

Related Experiment Video

Updated: Mar 8, 2026

Author Spotlight: Identification and Isolation of Quiescent Leukemia Stem Cells from Zebrafish T-ALL
06:41

Author Spotlight: Identification and Isolation of Quiescent Leukemia Stem Cells from Zebrafish T-ALL

Published on: July 19, 2024

1.5K

Zebrafish models of leukemia.

S He1, C-B Jing1, A T Look1

  • 1Harvard Medical School, Boston, MA, United States.

Methods in Cell Biology
|January 29, 2017
PubMed
Summary
This summary is machine-generated.

Zebrafish (Danio rerio) are crucial models for studying human cancers, especially hematopoietic malignancies. Their conserved genetics and unique traits enable research into cancer development and testing of new therapies.

Keywords:
AMLB-ALLLeukemiaMDSMPNT-ALLZebrafish

More Related Videos

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
08:32

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

Published on: February 22, 2019

7.6K
Normal and Malignant Muscle Cell Transplantation into Immune Compromised Adult Zebrafish
09:39

Normal and Malignant Muscle Cell Transplantation into Immune Compromised Adult Zebrafish

Published on: December 26, 2014

11.3K

Related Experiment Videos

Last Updated: Mar 8, 2026

Author Spotlight: Identification and Isolation of Quiescent Leukemia Stem Cells from Zebrafish T-ALL
06:41

Author Spotlight: Identification and Isolation of Quiescent Leukemia Stem Cells from Zebrafish T-ALL

Published on: July 19, 2024

1.5K
Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
08:32

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

Published on: February 22, 2019

7.6K
Normal and Malignant Muscle Cell Transplantation into Immune Compromised Adult Zebrafish
09:39

Normal and Malignant Muscle Cell Transplantation into Immune Compromised Adult Zebrafish

Published on: December 26, 2014

11.3K

Area of Science:

  • Comparative oncology
  • Genetics and developmental biology

Background:

  • Zebrafish (Danio rerio) are widely used for human cancer research due to conserved oncogenic pathways.
  • Their unique biological features make them ideal for studying cellular processes in human diseases.
  • Conservation of hematopoiesis between zebrafish and humans has led to models for blood cancers.

Purpose of the Study:

  • To highlight the zebrafish as an indispensable model for hematopoietic malignancies.
  • To showcase key examples of zebrafish models for human blood cancers.
  • To present recent advances in zebrafish cancer modeling.

Main Methods:

  • Utilizing transgenesis and genome-editing to create zebrafish cancer models.
  • Developing models for various human hematopoietic malignancies.
  • Analyzing molecular pathogenesis and preclinical therapies.

Main Results:

  • Established a wide spectrum of zebrafish models for human hematopoietic malignancies since 2003.
  • Demonstrated the utility of zebrafish in understanding cancer development.
  • Validated zebrafish as a tool for preclinical drug investigation.

Conclusions:

  • Zebrafish are invaluable for studying human cancers, particularly hematopoietic malignancies.
  • Zebrafish models accelerate the understanding of molecular pathogenesis.
  • These models are critical for expediting the preclinical investigation of novel cancer therapies.